Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
270
Trial Sponsor
Clinical Trial Start Date
2011
0Primary Completion Date
2017
0Study Completion Date
2017
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
NKTR-102 120 mg/m20
NKTR-102 95 mg/m20
NKTR-102 50 mg/m20
NKTR-102 145 mg/m20
Interventional Trial Phase
Phase 20
Official Name
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies0
Last Updated
July 12, 2021
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
The study objective of this open label, multicenter study is to provide access to NKTR-102 treatment to subjects previously enrolled in a NKTR-102 study who are without signs of disease progression since receiving NKTR-102. In addition the study will evaluate the safety of continued exposure to NKTR-102, observe disease status and survival status in subjects receiving NKTR-102, and evaluate the efficacy of NKTR-102 in subjects with advanced or metastatic solid tumors.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
